From Tools To Therapies: Stem Cell Maker CDI Takes One Small Step – Xconomy
|
From Tools To Therapies: Stem Cell Maker CDI Takes One Small Step
Xconomy There are plenty of regulatory hurdles, including a number of “safety pitfalls” that CDI “will have to avoid in their march to clinical application,” says Willy Lensch, executive director of Harvard University's department of stem cell and regenerative … MADISON – Sales rise for stem cell company CDI but so do expenses Susan A. Willetts Joins Cellular Dynamics' Board of Directors |
